Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
- PMID: 18200064
- DOI: 10.1038/sj.jid.5701213
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Abstract
The importance of T helper 17 (Th17) cells in inflammation and autoimmunity is now being appreciated. We analyzed psoriasis skin lesions and peripheral blood for the presence of IL-17-producing T cells. We localized Th17 cells predominantly to the dermis of psoriasis skin lesions, confirmed that IL-17 mRNA increased with disease activity, and demonstrated that IL-17 mRNA expression normalized with cyclosporine therapy. IL-22 mRNA expression mirrored IL-17 and both were downregulated in parallel with keratin 16. Th17 cells are a discrete population, separate from Th1 cells (which are also in psoriasis lesions), and Th2 cells. Our findings suggest that psoriasis is a mixed Th1 and Th17 inflammatory environment. Th17 cells may be proximal regulators of psoriatic skin inflammation, and warrant further attention as therapeutic targets.
Comment in
-
T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis.J Invest Dermatol. 2008 May;128(5):1064-7. doi: 10.1038/jid.2008.85. J Invest Dermatol. 2008. PMID: 18408745 Free PMC article. Review.
Similar articles
-
Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris.J Dermatol. 2012 Nov;39(11):916-21. doi: 10.1111/j.1346-8138.2012.01637.x. Epub 2012 Aug 23. J Dermatol. 2012. PMID: 22913391
-
The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.Int J Dermatol. 2015 Jul;54(7):e254-60. doi: 10.1111/ijd.12834. Int J Dermatol. 2015. PMID: 26108267
-
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.Gut. 2014 Apr;63(4):567-77. doi: 10.1136/gutjnl-2012-302853. Epub 2013 Mar 6. Gut. 2014. PMID: 23468464
-
Cytokine network in psoriasis revisited.Eur Cytokine Netw. 2011 Dec;22(4):160-8. doi: 10.1684/ecn.2011.0294. Eur Cytokine Netw. 2011. PMID: 22236965 Review.
-
Interleukin 17A: toward a new understanding of psoriasis pathogenesis.J Am Acad Dermatol. 2014 Jul;71(1):141-50. doi: 10.1016/j.jaad.2013.12.036. Epub 2014 Mar 18. J Am Acad Dermatol. 2014. PMID: 24655820 Review.
Cited by
-
Th17 response and inflammatory autoimmune diseases.Int J Inflam. 2012;2012:819467. doi: 10.1155/2012/819467. Epub 2011 Nov 15. Int J Inflam. 2012. PMID: 22229105 Free PMC article.
-
CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity.Braz J Med Biol Res. 2016 Aug 15;49(9):e5374. doi: 10.1590/1414-431X20165374. Braz J Med Biol Res. 2016. PMID: 27532281 Free PMC article.
-
New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors.Dermatol Ther. 2015 Jul-Aug;28(4):179-93. doi: 10.1111/dth.12251. Dermatol Ther. 2015. PMID: 26201310 Free PMC article. Review.
-
Immunophenotype lymphocyte of peripheral blood in patients with psoriasis.Med Arch. 2014 Aug;68(4):236-8. doi: 10.5455/medarh.2014.68.236-238. Epub 2014 Jul 31. Med Arch. 2014. PMID: 25568543 Free PMC article.
-
Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer.J Biomed Biotechnol. 2012;2012:147413. doi: 10.1155/2012/147413. Epub 2012 Jun 12. J Biomed Biotechnol. 2012. PMID: 22754278 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials